Caffeine (6mg/kg): Anhydrous caffeine administered in an encapsulated form at a dosage of 6mg per kilogram of body mass, 30-60 minutes before the exercise protocol.
Placebo (Starch capsule): Corn starch administered in an identical encapsulated form as the active caffeine, 30-60 minutes before the exercise protocol.
Sham (No Treatment): Participants perform the same exercise protocols without any capsule or substance administration.
Study summary
This study aims to investigate the placebo (PLA) effect on physical performance across different sports disciplines in real-world, field-based settings. The study investigates how participant expectations and beliefs regarding caffeine (CAF) intake influence physical performance and psychomotor function outside the controlled laboratory environment. Healthy, physically active adults (n = 120) from diverse sports backgrounds will be randomly assigned to receive caffeine, placebo, or no intervention. Participants will perform discipline-specific field exercise tests (e.g., running-based protocols or repeated sprint protocols) while physiological responses are monitored using wearable technology. Physical performance outcomes and psychomotor responses will be analyzed to evaluate the real-world impact of the placebo effect and to distinguish the pharmacological effects of caffeine from those driven by psychological expectations across different athletic settings.
Eligibility
Sex
ALL
Min age
20 Years
Max age
35 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Age between 20 and 35 years,
* Healthy adults,
* Regular physical activity,
* Normal or corrected-to-normal vision,
* Habitual caffeine consumption.
Exclusion Criteria:
* History of neurological, psychiatric, cardiovascular, or metabolic disorders,
* Current use of medication or supplements affecting the central nervous system,
* Musculoskeletal injuries that would impair physical performance,
* No habitual caffeine consumption or severe negative side effects of caffeine,
* Diagnosed sleep disorders or chronic fatigue,
* Diagnosed major depressive disorder or other severe psychiatric conditions,
* Presence of any menstrual disorders,
* Inability to attend all experimental study visits.
Primary outcome measure(s)
Physical Performance Capacity (total distance in running, metres) — Measured during the exercise protocol immediately following administration of the study intervention. Total physical work capacity measured as the total running distance (metres) completed during the standardized exercise protocol.
Physical Performance Capacity (total work in Joules for cycling) — Measured during the exercise protocol immediately following administration of the study intervention. Total physical work capacity measured as the total mechanical work (Joules) completed during the standardized cycling exercise protocol.
Physical Performance Capacity (exercise duration until exhaustion, minutes) — Measured during the exercise protocol immediately following administration of the study intervention. Total physical work capacity measured as exercise duration until volitional exhaustion during the standardized exercise protocol.
Trial sites (1)
Facility
City
Region
Status
Poznan University of Physical Education
Poznan
Greater Poland Voivodeship
More Poznan University of Physical Education trials in Poland
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.